CASI Pharmaceuticals (CASIF) Q4 2025 Earnings

14NovConfirmed
Q1 1
Q4 2025
-0.68
-0.57
-0.47
-0.36

Details

Expected EPS
-0.4
Actual EPS
-0.68
Surprise EPS
-0.28
Surprise Percent
+70%

Description

CASI Pharmaceuticals (CASIF) has reported earnings of -0.68 per share for Q4 2025.

0 Comments

Share your thoughts